This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.

 
Web www.patentalert.com

< Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

> Surface modification of lactose excipient for use in powders for inhalation

> Reversible Hydrophobic Modification of Drugs for Improved Delivery to Cells
~ 00547